Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Atrial support pacing in heart failure: results from the multicenter PEGASUS CRT trial.

Martin DO, Day JD, Lai PY, Murphy AL, Nayak HM, Villareal RP, Weiner S, Kraus SM, Stolen KQ, Gold MR.

J Cardiovasc Electrophysiol. 2012 Dec;23(12):1317-25. doi: 10.1111/j.1540-8167.2012.02402.x. Epub 2012 Jul 25.

PMID:
22830441
2.

Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): design and rationale.

Martin DO, Stolen KQ, Brown S, Yu Y, Christie C, Doshi SK, Smith JM, Gold MR, Day JD.

Am Heart J. 2007 Jan;153(1):7-13.

PMID:
17174627
3.

Efficacy of cardiac resynchronization therapy in very old patients: the Insync/Insync ICD Italian Registry.

Achilli A, Turreni F, Gasparini M, Lunati M, Sassara M, Santini M, Landolina M, Padeletti L, Puglisi A, Bocchiardo M, Orazi S, Perego GB, Valsecchi S, Denaro A.

Europace. 2007 Sep;9(9):732-8. Epub 2007 Jul 18.

PMID:
17636304
4.

Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.

Gasparini M, Lunati M, Santini M, Tritto M, Curnis A, Bocchiardo M, Vincenti A, Pistis G, Valsecchi S, Denaro A; INSYNC/INSYNC ICD ITALIAN Registry Investigators.

Pacing Clin Electrophysiol. 2006 Dec;29 Suppl 2:S2-10.

PMID:
17169128
5.

The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.

Ng K, Kedia N, Martin D, Tchou P, Natale A, Wilkoff B, Starling R, Grimm RA.

Pacing Clin Electrophysiol. 2007 Feb;30(2):193-8.

PMID:
17338715
6.

The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.

Wilkoff BL; Dual Chamber and VVI Implantable Defibrillator trial investigators.

Card Electrophysiol Rev. 2003 Dec;7(4):468-72.

PMID:
15071277
7.

Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age.

Brambatti M, Guerra F, Matassini MV, Cipolletta L, Barbarossa A, Urbinati A, Marchesini M, Capucci A.

Europace. 2013 May;15(5):704-10. doi: 10.1093/europace/eus376. Epub 2013 Feb 5.

PMID:
23385052
8.

Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.

Lepillier A, Piot O, Gerritse B, Copie X, Lavergne T, Paziaud O, Lascault G, Waintraub X, Otmani A, Le Heuzey JY.

Europace. 2009 Jan;11(1):80-5. doi: 10.1093/europace/eun288. Epub 2008 Oct 24.

PMID:
18952828
9.

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group.

J Am Coll Cardiol. 2008 Dec 2;52(23):1834-43. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.

10.

Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population.

Foley PW, Chalil S, Khadjooi K, Smith RE, Frenneaux MP, Leyva F.

Europace. 2008 Nov;10(11):1302-7. doi: 10.1093/europace/eun263. Epub 2008 Sep 30.

PMID:
18827063
11.

Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors.

Bai R, Di Biase L, Elayi C, Ching CK, Barrett C, Philipps K, Lim P, Patel D, Callahan T, Martin DO, Arruda M, Schweikert RA, Saliba WI, Wilkoff B, Natale A.

J Cardiovasc Electrophysiol. 2008 Dec;19(12):1259-65. doi: 10.1111/j.1540-8167.2008.01234.x. Epub 2008 Jul 3.

PMID:
18631272
12.

Rate-responsive pacing in patients with heart failure: long-term results of a randomized study.

Nägele H, Rödiger W, Castel MA.

Europace. 2008 Oct;10(10):1182-8. doi: 10.1093/europace/eun213. Epub 2008 Aug 21.

PMID:
18723519
13.

Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy.

Kronborg MB, Albertsen AE, Nielsen JC, Mortensen PT.

Europace. 2009 Sep;11(9):1177-82. doi: 10.1093/europace/eup202. Epub 2009 Aug 6.

PMID:
19661114
14.

Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.

Boriani G, Gasparini M, Landolina M, Lunati M, Proclemer A, Lonardi G, Iacopino S, Rahue W, Biffi M, DiStefano P, Grammatico A, Santini M; ClinicalService cardiac centres.

Eur J Heart Fail. 2011 Aug;13(8):868-76. doi: 10.1093/eurjhf/hfr046. Epub 2011 May 10.

15.

Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).

Healey JS, Hohnloser SH, Exner DV, Birnie DH, Parkash R, Connolly SJ, Krahn AD, Simpson CS, Thibault B, Basta M, Philippon F, Dorian P, Nair GM, Sivakumaran S, Yetisir E, Wells GA, Tang AS; RAFT Investigators.

Circ Heart Fail. 2012 Sep 1;5(5):566-70. Epub 2012 Aug 14.

16.

Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.

Nägele H, Behrens S, Eisermann C.

Europace. 2008 Dec;10(12):1375-80. doi: 10.1093/europace/eun257. Epub 2008 Sep 5.

PMID:
18776196
17.

Effect of pacing for soft indications on mortality and heart failure in the dual chamber and VVI implantable defibrillator (DAVID) trial.

Kutalek SP, Sharma AD, McWilliams MJ, Wilkoff BL, Leonen A, Hallstrom AP, Kudenchuk PJ; DAVID Investigators.

Pacing Clin Electrophysiol. 2008 Jul;31(7):828-37. doi: 10.1111/j.1540-8159.2008.01106.x.

PMID:
18684279
18.

Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival.

Manne M, Rickard J, Varma N, Chung MK, Tchou P.

Pacing Clin Electrophysiol. 2013 Aug;36(8):970-7. doi: 10.1111/pace.12174. Epub 2013 May 29.

PMID:
23718783
19.

Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).

Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, Bianchi S, Laurenzi F, Curnis A, Vincenti A, Valsecchi S, Denaro A; InSync/InSync ICD Italian Registry Investigators.

Am J Cardiol. 2007 Sep 15;100(6):1007-12. Epub 2007 Jul 5.

PMID:
17826388
20.

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.

Schuchert A, Muto C, Maounis T, Frank R, Boulogne E, Polauck A, Padeletti L; MASCOT study group.

Europace. 2013 Jan;15(1):71-6. doi: 10.1093/europace/eus247. Epub 2012 Aug 26.

PMID:
22927665

Supplemental Content

Support Center